Accelerate Diagnostics (AXDX) Stock Chart & Stock Price History → Could this Tiny Biotech End Disease Forever? (From Behind the Markets) (Ad) Free AXDX Stock Alerts $0.93 +0.03 (+3.70%) (As of 01:20 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Accelerate Diagnostics Stock Price Performance5 Day Performance-2.68%1 Month Performance-1.12%3 Month Performance-30.23%6 Month Performance-84.38%Year-To-Date Performance-77.04%1 Year Performance-88.61% Receive AXDX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Accelerate Diagnostics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaIncredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide AXDX Stock Chart for Wednesday, May, 8, 2024 AXDX Chart by TradingView Accelerate Diagnostics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$0.92$0.90-2.17%$0.99$0.9021,124 shs$19.49 million05/06/2024$0.92$0.92-0.52%$0.98$0.9028,983 shs$19.93 million05/03/2024$0.94$0.92-1.82%$0.98$0.9226,876 shs$20.03 million05/02/2024$0.94$0.94+0.71%$0.95$0.8937,665 shs$20.40 million05/01/2024$0.88$0.94+6.09%$0.95$0.8815,183 shs$20.26 million04/30/2024$0.92$0.88-4.45%$0.95$0.8812,108 shs$19.10 million Get the Latest News and Ratings for AXDX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Accelerate Diagnostics and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$0.93$0.92-0.80%$0.94$0.889,986 shs$19.99 million04/26/2024$0.94$0.93-0.59%$0.95$0.894,924 shs$20.15 million04/25/2024$0.93$0.94+0.49%$0.95$0.8914,119 shs$20.27 million04/24/2024$0.95$0.93-2.00%$0.95$0.8712,785 shs$20.17 million04/23/2024$0.89$0.95+7.05%$1.01$0.89137,854 shs$20.58 million04/22/2024$0.86$0.89+3.31%$0.94$0.8618,341 shs$19.22 million04/19/2024$0.77$0.86+11.56%$0.88$0.7737,732 shs$18.61 million04/18/2024$0.74$0.77+4.55%$0.80$0.7334,997 shs$16.68 million04/17/2024$0.82$0.74-9.73%$0.85$0.73122,910 shs$15.95 million04/16/2024$0.88$0.82-6.75%$0.93$0.8245,264 shs$17.67 million04/15/2024$0.89$0.88-1.46%$0.93$0.8619,224 shs$18.95 million04/12/2024$0.90$0.89-1.33%$0.90$0.8570,338 shs$19.23 million04/11/2024$0.89$0.90+1.12%$0.95$0.8840,852 shs$19.49 million04/10/2024$0.86$0.89+3.49%$0.90$0.8627,311 shs$19.28 million04/09/2024$0.91$0.86-5.52%$0.91$0.8594,419 shs$18.63 million04/08/2024$0.84$0.91+8.75%$0.93$0.8361,063 shs$19.72 million04/05/2024$0.84$0.84-0.35%$0.89$0.8335,306 shs$12.20 million04/04/2024$0.91$0.84-7.23%$0.90$0.83116,832 shs$12.24 million04/03/2024$0.94$0.91-3.70%$0.94$0.9060,889 shs$13.19 million04/02/2024$0.89$0.94+5.78%$0.96$0.89193,708 shs$13.70 million04/01/2024$0.99$0.89-10.22%$0.97$0.89224,515 shs$12.95 million03/29/2024$0.99$0.99$1.05$0.9886,630 shs$14.42 million03/28/2024$1.01$0.99-1.98%$1.05$0.9886,531 shs$14.42 million03/27/2024$0.96$1.01+5.18%$1.09$0.9686,805 shs$14.72 million03/26/2024$1.00$0.96-3.97%$1.00$0.9599,954 shs$13.99 million03/25/2024$0.99$1.00+1.01%$1.02$0.9538,886 shs$14.57 million03/22/2024$0.98$0.99+1.00%$1.02$0.9540,601 shs$14.42 million03/21/2024$0.99$0.98-1.00%$1.02$0.9666,873 shs$14.28 million03/20/2024$0.97$0.99+2.05%$1.01$0.9536,094 shs$14.43 million03/19/2024$0.98$0.97-1.00%$0.99$0.9554,116 shs$14.14 million03/18/2024$0.95$0.98+3.16%$1.01$0.9563,197 shs$14.28 million03/15/2024$1.00$0.95-5.00%$1.00$0.95144,458 shs$13.84 million03/14/2024$1.08$1.00-7.41%$1.08$0.9648,585 shs$14.57 million03/13/2024$1.05$1.08+2.86%$1.08$1.0038,513 shs$15.74 millionCould this Tiny Biotech End Disease Forever? (Ad)Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.Access my full "Cut & Paste" profit analysis now.03/12/2024$1.14$1.05-7.89%$1.13$1.0070,119 shs$15.30 million03/11/2024$1.15$1.14-0.87%$1.19$1.1126,369 shs$16.61 million03/08/2024$1.08$1.15+6.48%$1.19$1.0748,787 shs$16.76 million03/07/2024$1.10$1.08-1.82%$1.19$1.0667,251 shs$15.74 million03/06/2024$1.06$1.10+3.77%$1.19$1.06112,343 shs$16.03 million03/05/2024$1.03$1.06+2.91%$1.08$1.0570,829 shs$15.44 million03/04/2024$0.97$1.03+6.19%$1.09$0.97137,113 shs$15.01 million03/01/2024$0.99$0.97-1.53%$1.08$0.9521,701 shs$14.13 million02/29/2024$0.93$0.99+6.21%$1.00$0.9553,405 shs$14.35 million02/28/2024$0.91$0.93+1.92%$1.01$0.9045,862 shs$13.51 million02/27/2024$0.96$0.91-5.21%$1.01$0.8645,577 shs$13.26 million02/26/2024$0.97$0.96-1.03%$1.05$0.9062,625 shs$13.99 million02/23/2024$0.95$0.97+2.11%$1.03$0.8366,732 shs$14.13 million02/22/2024$1.14$0.95-16.67%$1.19$0.93166,438 shs$13.84 million02/21/2024$1.18$1.14-3.39%$1.17$1.1121,360 shs$16.61 million02/20/2024$1.18$1.18$1.24$1.1068,339 shs$17.19 million02/19/2024$1.18$1.18$1.23$1.1033,600 shs$17.19 million02/16/2024$1.19$1.18-0.84%$1.23$1.1033,665 shs$17.19 million02/15/2024$1.22$1.19-2.46%$1.28$1.1830,262 shs$17.34 million02/14/2024$1.20$1.22+1.67%$1.24$1.2039,293 shs$17.78 million02/13/2024$1.18$1.20+1.69%$1.22$1.1825,806 shs$17.48 million02/12/2024$1.20$1.18-1.67%$1.29$1.1559,009 shs$17.19 million02/09/2024$1.29$1.20-6.98%$1.35$1.1853,488 shs$17.48 million02/08/2024$1.16$1.29+11.21%$1.33$1.15179,164 shs$18.80 million02/07/2024$1.17$1.16-0.85%$1.20$1.1322,567 shs$16.90 million Related Companies: HLTH Stock Chart TLIS Stock Chart TBIO Stock Chart OMIC Stock Chart PRPO Stock Chart RPID Stock Chart BNGO Stock Chart ATPC Stock Chart APTO Stock Chart APM Stock Chart Receive AXDX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Accelerate Diagnostics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AXDX) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe #1 lithium battery stock to have on your radar in 2024!Smallcaps Daily[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsThe AI Stock that’s Disrupting Every IndustryStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Accelerate Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.